News Development of a next-generation dual-target rabies/flavivirus infectious vaccine Webinar Welcome to the webinar page of our H2020 RABYD-VAX project! Instead of organizing a symposium, we opted to organize a webinar to cover diverse topics in the rabies field. A webinar will allow us to reach more people worldwide, and hence in the same time save carbon foot print! A tentative program can be found here below. We are proud to present many eminent speakers in the rabies field, this webinar will be certainly one to watch! Moreover, the talks will be broadcasted for a longer period of time, giving people all around the world/within different time zones the ability to watch at their own convenience. Accessible online as off the 14th of January 2020, 10 CET. A question poll system will be implemented whereby viewers can type their question(s) to the speaker. By a voting system other viewers will be able to vote the most pertinent questions upwards and these will be addressed by the speaker. This poll will be open for one month. Afterwards a Q&A section will become available on this webpage. Register here! Rabies Webinar – 14th of January 2020 Rabies Pathogenesis & Immunity Rabies virus: General introduction – Anthony Fooks, APHA, London, UK & Steven Van Gucht, Sciensano, Brussels, Belgium Rabies virus pathogenesis and immunity…what happens? – Hildegund Ertl, The Wistar Institute, Philadelphia, PA, USA Rabies virus immunology – Monique Lafon, Institute Pasteur Paris, France Current Rabies Prophylaxis – Human & Dog Massive rabies pre-exposure prophylaxis: New paradigm that saves lives when everything else fails – Sergio Recuenco, Universidad Nacional Mayor de San Marcos, Peru Research and field application of oral vaccines for wildlife rabies control – Amy Gilbert, United States Department of Agriculture, River Dale, USA Importance of active and passive immunization in human rabies prophylaxis and technological improvements contributing to its efficiency and safety – Srðan Stankov, Pasteur Institute in Novi Sad, Serbia Practical applications in eliminating canine transmitted rabies – Luke Gamble, Mission Rabies, Dorset, UK Postexposure Prophylaxis in Domestic Animals – Charles Rupprecht, USA Modeling the Potential Impact of Scaling Up Use of Human and Dog Vaccines to Prevent Deaths from Dog-Mediated Rabies? – Katie Hampson, University of Glasgow, UK Abridged rabies vaccine schedules in Belgian soldiers: can we also promote these simplified rabies vaccine schedules in endemic countries? – Patrick Soentjens, Institute for Tropical Medicine, Antwerp, Belgium Improving the access to rabies post-exposure prophylaxis – Hervé Bourhy, Institute Pasteur, Paris, France Rabies Epidemiology & Public health Rabies Landscape in the Philippines: Lessons from Davao City – Lyre Murao, University of the Philippines Mindanao, Philippines Rabies in the Caribbean – Janine Seetahal, University of the West Indies, St. Augustine, Trinidad and Tobago WHO 2018 recommendations on rabies prophylaxis: Contentious issues for India – M.K.Sudarshan, Kempegowda Institute of Medical Sciences, Bengaluru, Karnataka, India Rabies in Brazil – Ivanete Kotait, Venco Saúde Animal, Londrina, Brazil Ongoing Innovations for Treatment – Towards a Cure: Antivirals & Vaccines Treatment of human rabies – Rodney Willoughby, Medical College of Wisconsin/Children’s Hospital of Wisconsin, WI, USA The animal model to develop innovative protocols for rabies post-exposure and therapy in humans: constraints and opportunities – Paola De Benedictis, National and FAO Reference Centre for Rabies, Padua, Italy A novel dual vaccine against rabies and yellow fever virus, PLLAV – Kai Dallmeier, Lorena Sanchez Felipe, University of Leuven, Leuven, Belgium Antivirals against rabies – Johan Neyts and Dirk Jochmans, University of Leuven, Leuven, Belgium Overcoming barriers to rabies innovation: how to align interests of relevant stakeholders – Linda van de Burgwal, University of Amsterdam, Amsterdam, The Netherlands Provided by:   Lotte Coelmont, PhD Innovation Manager +32 16 32 17 08 Rega Institute for Medical Research | University of Leuven Herestraat 49, box 1043 | 3000 Leuven | Belgium